• licensed medical cannabis

    KB Cannabis Project

    European medicinal cannabis market is a key target for pharmaceutical companies over the next decade, as various researches and studies indicate that it will be the largest medicinal cannabis market in the world. Europe’s medicinal cannabis market value is estimated to be worth €20.2B by 2024 (Nov 2019, The Global Cannabis Report) and €58B by 2028 (Jan 2019, The European Cannabis Report) according to Prohibition Partners. For Germany in particular, the largest medicinal cannabis market in Europe today, Prohibition Partners forecasts a growth in market value from €73.7M in 2018 to €7.7B by 2028 (Oct 2019, The German Cannabis Report). According to Global Market Insights Inc (Aug 2019) medicinal cannabis market in Germany is projected to grow between 2017 and 2024 with compound annual growth rate (CAGR) of 49.5%.

    KB ENERGY ltd, an officially authorized licensed medicinal cannabis producer in Greece*, wants to establish itself, through the ‘KB Cannabis Project', in the European market as one of the pioneers in the production of finished medicinal products of cannabis. To achieve its goal and ensure its success, KB ENERGY ltd will offer to the European market products evaluated and approved by the National Organisation for Medicines (EOF) by adopting the latest technology in the cultivation, production, processing and standardization of medicinal cannabis products in its EU GMP compliant vertical production unit, the implementation of which has already begun. Τhe facility is located in Western Greece, on a privately owned area of 16.000 m2 and has a production capacity of about 21.000.000 grams of dry inflorescence per year.

    * ref. Government Gazette of the Hellenic Republic, June 20, 2019, ISSUE TWO, Sheet no. 2431

  • KB Cannabis Project

    European medicinal cannabis market is a key target for pharmaceutical companies over the next decade, as various researches and studies indicate that it will be the largest medicinal cannabis market in the world. Europe’s medicinal cannabis market value is estimated to be worth €20.2B by 2024 (Nov 2019, The Global Cannabis Report) and €58B by 2028 (Jan 2019, The European Cannabis Report) according to Prohibition Partners. For Germany in particular, the largest medicinal cannabis market in Europe today, Prohibition Partners forecasts a growth in market value from €73.7M in 2018 to €7.7B by 2028 (Oct 2019, The German Cannabis Report). According to Global Market Insights Inc (Aug 2019) medicinal cannabis market in Germany is projected to grow between 2017 and 2024 with compound annual growth rate (CAGR) of 49.5%.

    KB ENERGY ltd, an officially authorized licensed medicinal cannabis producer in Greece*, wants to establish itself, through the ‘KB Cannabis Project', in the European market as one of the pioneers in the production of finished medicinal products of cannabis. To achieve its goal and ensure its success, KB ENERGY ltd will offer to the European market products evaluated and approved by the National Organisation for Medicines (EOF) by adopting the latest technology in the cultivation, production, processing and standardization of medicinal cannabis products in its EU GMP compliant vertical production unit, the implementation of which has already begun. Τhe facility is located in Western Greece, on a privately owned area of 16.000 m2 and has a production capacity of about 21.000.000 grams of dry inflorescence per year.

    * ref. Government Gazette of the Hellenic Republic, June 20, 2019, ISSUE TWO, Sheet no. 2431

KB ENERGY ltd

255th km Athens - Ioannina National Road | Etoliko | PC 30400 | GREECE

tel. +30 2632022080-1 | fax. +30 2632023334 | email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Web Design Web Builders